Treatment Patterns of Neratinib in HER2+ EBC in China
Clinical trial NCT05491057 · UNKNOWN
Trial details
- NCT number
- NCT05491057
- Sponsor
- Pierre Fabre Medicament
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-30
- Primary completion
- 2025-12-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.